IDEAYA Biosciences (IDYA) Change in Account Payables (2018 - 2026)
IDEAYA Biosciences (IDYA) reported Change in Account Payables of $3.0 million for Q1 2026, up 11.8% on a YoY basis from $2.7 million in Q1 2025, and up 455.48% sequentially from -$858000.0 in Q4 2025.
IDEAYA Biosciences (IDYA) Change in Account Payables (2018 - 2026) Analysis & Trends
IDEAYA Biosciences (IDYA) has 9 years of Change in Account Payables data on file, last reported at $3.0 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Account Payables rose 11.8% year-over-year to $3.0 million; the trailing twelve-month figure through Mar 2026 stood at $3.0 million (down 73.66% YoY), and the FY2025 full-year result was $2.7 million, down 67.43% from the prior year.
- Change in Account Payables climbed to $3.0 million in Q1 2026, from -$858000.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $9.7 million in Q2 2024 to a low of -$3.9 million in Q3 2024.
- A 5-year average of $1.1 million and a median of $863000.0 in 2022 frame the typical range for Change in Account Payables.
- Across the five-year window, Change in Account Payables soared 5771.43% in 2022 and plunged 3675.0% in 2024, its largest moves.
- Tracing IDYA's Change in Account Payables over 5 years: stood at $397000.0 in 2022, then jumped by 339.55% to $1.7 million in 2023, then soared by 70.54% to $3.0 million in 2024, then tumbled by 128.83% to -$858000.0 in 2025, then soared by 455.48% to $3.0 million in 2026.
- Business Quant data shows IDYA's Change in Account Payables at $3.0 million in Q1 2026, -$858000.0 in Q4 2025, and $1.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | IDEAYA Biosciences | 3.21 Bn | 2.54 Bn | - | 3.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.05 Mn |
| Mar 31, 2026 | 3.05 Mn |
| Dec 31, 2025 | -858,000.00 |
| Dec 31, 2025 | -858,000.00 |
| Sep 30, 2025 | 1.19 Mn |
| Sep 30, 2025 | 1.19 Mn |
| Jun 30, 2025 | -364,000.00 |
| Jun 30, 2025 | -364,000.00 |
| Mar 31, 2025 | 2.73 Mn |
| Mar 31, 2025 | 2.73 Mn |
| Dec 31, 2024 | 2.98 Mn |
| Dec 31, 2024 | 2.98 Mn |
| Sep 30, 2024 | -3.94 Mn |
| Sep 30, 2024 | -3.94 Mn |
| Jun 30, 2024 | 9.70 Mn |
| Jun 30, 2024 | 9.70 Mn |
| Mar 31, 2024 | -453,000.00 |
| Mar 31, 2024 | -453,000.00 |
| Dec 31, 2023 | 1.75 Mn |
| Dec 31, 2023 | 1.75 Mn |